Optimization of Capecitabine-Loaded Niosomes Using Factorial Design: An Approach for Enhanced Drug Release and Cytotoxicity in Breast Cancer
Authors:
- 11 February 2025
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (2) , 1-14
Abstract
Capecitabine, an oral prodrug of 5-fluorouracil, is increasingly being loaded into various drug delivery system to enhance its bioavailability and cytotoxiKeywords
This publication has 49 references indexed in Scilit:
- Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activityBiomedicine & Pharmacotherapy, 2017
- Nanomedicine applications in the treatment of breast cancer: current state of the artInternational Journal of Nanomedicine, 2017
- RETRACTED: Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s)Biomedicine & Pharmacotherapy, 2017
- Investigation of Formulation Variables and Excipient Interaction on the Production of NiosomesAAPS PharmSciTech, 2012
- Formulation and evaluation of Ketoconazole niosomal gel drug delivery systemInternational Journal of Pharmaceutical Investigation, 2012
- Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 32 Factorial DesignScientia Pharmaceutica, 2012
- Formulation and Evaluation of Niosomes2011
- Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: Physicochemical characterization2010
- Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral deliveryJournal of Pharmaceutical Sciences, 2010
- Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsCancer Chemotherapy and Pharmacology, 2000